Olive Leaf Extract: What the Evidence Actually Says About the Mediterranean Longevity Compound
Olive Leaf Extract: What the Evidence Actually Says About the Mediterranean Longevity Compound
If the Mediterranean diet had a single plant to thank for its longevity reputation, the olive tree would be it — and its leaves may be the part we've been throwing away. For centuries, olive oil stole the spotlight while the leaves were fed to livestock. Then researchers noticed that the same bitter compound that protects the tree from pests and drought — oleuropein — also switches on the body's own longevity pathways. A 621-person trial has now shown a daily olive leaf extract lowers blood pressure about as well as a low-dose drug, and a 2025 trial found it shifted actual markers of tissue aging in postmenopausal women. Here is what olive leaf extract actually does, where the proof still falls short, and whether it belongs in your stack.
📋 Simple Summary
Olive leaf extract is a supplement made from the leaves of the olive tree. Its main active compound, oleuropein, is one of the reasons the Mediterranean diet is linked to longer life. The strongest human evidence is for blood pressure: a 2025 trial of 621 people with high blood pressure found olive leaf extract lowered their 24-hour blood pressure by 6.4 points on the top number — roughly what a low-dose medication achieves. It also reliably lowers triglycerides, and one small trial found it shifted real markers of tissue aging (collagen, elastin, and a marker called MMP-2) in postmenopausal women. The main cautions are that it can stack with blood-pressure and diabetes drugs (so it needs monitoring), and that no trial has yet proven it extends human lifespan itself. Bottom line: a well-evidenced, low-risk supplement for cardiovascular aging, with promising — but not yet proven — anti-aging signals.
The detailed breakdown continues below for those who want the full science.
Published: August 16, 2026
Evidence Tier: 🥈 Silver — multiple human RCTs and meta-analyses for blood pressure and cardiometabolic markers (Gold-level for those outcomes), plus one direct tissue-aging trial, but no human lifespan data
Category: Supplements & Compounds
⚖️ At a Glance: Pros & Cons
⚠️ We are researchers, not doctors. Nothing on this page is medical advice. Talk to your doctor before taking any supplement. The information below is for education only.
✅ Pros (What the Evidence Supports)
- Strongest benefit: A 621-person, double-blind RCT cut 24-hour systolic blood pressure by 6.4 mmHg versus 1.5 mmHg for placebo — on par with a low-dose drug (PMID 40990594).
- Cardiometabolic: Meta-analyses of 12+ randomized trials show consistent reductions in triglycerides, LDL, and fasting blood sugar (PMID 36271405, 38287654).
- Direct aging signal: In a 65-woman RCT, 250 mg/day for 12 weeks shifted tissue-aging markers (elastin, collagen, MMP-2, advanced glycation end-products) in the right direction (PMID 41340653).
- Safety: Olive leaf is a food with a centuries-long history, and trials report few side effects and good tolerability.
❌ Cons (What the Evidence Doesn't Support or Warns About)
- Biggest limitation: No human trial has shown olive leaf extends lifespan or slows biological aging itself — the longevity claim rests on mechanism plus surrogate markers.
- Double-edged blood-pressure effect: The same mechanism that helps high blood pressure can stack with BP drugs and cause dizziness or low pressure in some people.
- Bioavailability question: Oleuropein is poorly absorbed and heavily broken down, so how much actually reaches your tissues is still debated.
- Who should avoid: Anyone on blood-pressure or diabetes medication (needs monitoring), pregnant or breastfeeding women, and people with olive or pollen allergies.
What Is Olive Leaf Extract?
Olive leaf extract (OLE) is a concentrated extract of the leaves of the olive tree (Olea europaea) — the same tree that gives us olive oil, but a different part of it. Its dominant active compound is oleuropein, a bitter polyphenol the tree produces as a natural pesticide and drought shield. Alongside oleuropein, the leaves contain smaller amounts of hydroxytyrosol, verbascoside, and other phenolics (PMID 39162269).
Oleuropein is what researchers call a secoiridoid — a class of plant compounds unusually abundant in olives. It is the same family of molecules behind extra-virgin olive oil's much-studied benefits, and several reviews name oleuropein and hydroxytyrosol as the two compounds most responsible for olive's antioxidant and anti-inflammatory effects (PMID 39162269, 42588039).
One practical point worth knowing up front: olive leaf extract is far more concentrated in these polyphenols than olive oil is. A daily supplement can deliver oleuropein doses that would be hard to reach through diet alone — which is exactly why it is studied as a supplement rather than just a food.
How It Works
Oleuropein and the other olive polyphenols act through several mechanisms that map directly onto how the body changes with age:
- AMPK activation (the "metformin-like" switch): Oleuropein activates AMPK — a cellular energy sensor that mimics some effects of calorie restriction and is the same pathway metformin and berberine act on. In human skeletal-muscle cells, oleuropein aglycone switched on AMPK and FOXO3a, boosting autophagy (cellular cleanup) and mitochondrial function while reducing oxidative stress by roughly 43% (PMID 41257461).
- Anti-inflammatory action (NF-κB): Oleuropein suppresses NF-κB, the master switch behind the chronic, low-grade "inflammaging" that accelerates age-related disease, and dials down pro-inflammatory signals (PMID 41082645, 42261702).
- Mitochondrial support: In nerve cells, oleuropein and hydroxytyrosol increased mitochondrial function and biogenesis — the creation of new mitochondria — through estrogen-like signaling (PMID 42299956).
- Anti-senescence (senomorphic): Oleuropein lowered markers of cellular senescence — the "zombie" cells that stop dividing but keep leaking inflammation — and restored function in aging cells, improving wound healing in the process (PMID 41727190).
- Epigenetic modulation: Olive bioactives act as natural histone deacetylase (HDAC) inhibitors, meaning they may influence which genes get switched on or off — one proposed route by which diet "programs" slower aging (PMID 42371247).
- Gut-microbiome and antioxidant effects: Olive polyphenols also shift the gut microbiome toward a healthier profile and raise the body's own antioxidant defenses (PMID 42514304).
The Longevity Connection
🫀 Blood pressure — the strongest human evidence (Gold-level). The flagship trial is Lamti 2025: 621 adults with treated hypertension took olive leaf extract or placebo for 12 weeks. The extract lowered 24-hour systolic blood pressure by 6.4 mmHg versus 1.5 mmHg on placebo (P < 0.01), and reduced systolic "blood-pressure load" from 53.9% to 42.2% (PMID 40990594). A second 2026 trial combining olive leaf (1,000 mg) with potassium (300 mg) lowered morning home systolic pressure by 5.4 mmHg more than placebo (PMID 41935461). A dedicated 2025 meta-analysis confirmed olive leaf improves blood pressure in pre-hypertensive and hypertensive adults (PMID 40325976). Because high blood pressure is one of the leading drivers of cardiovascular death, this effect alone carries real longevity weight.
🩸 Cardiometabolic markers. A 2022 meta-analysis of 12 randomized trials (819 participants) found olive leaf extract significantly lowered triglycerides (by about 9.5 mg/dL) and systolic blood pressure (PMID 36271405). A 2024 meta-analysis of 12 RCTs reached similar conclusions for cardiometabolic risk factors (PMID 38287654). A 2023 trial also found olive leaf (inside a low-dose red-yeast-rice formula) helped lower LDL cholesterol (PMID 37375586).
🕰️ Direct tissue-aging markers — the most "longevity-relevant" human data. The Lasfar 2025 trial gave 65 postmenopausal women (45–70) either 250 mg of olive leaf extract or placebo daily for 12 weeks, then measured circulating markers of tissue aging and remodeling. The extract shifted elastin, collagen, hydroxyproline, MMP-2, and advanced glycation end-products (AGEs) — all markers tied to how connective tissue ages — in a favorable direction (PMID 41340653). It is one of the few supplement trials to measure aging biomarkers directly rather than infer them from a disease outcome.
🦷 The OLIVAGING trial. A 2026 randomized trial named OLIVAGING (NCT05482373) tested an oleuropein-enriched extract (40% oleuropein) in 60 adults aged 50+ with periodontitis — a gum disease that accelerates with age and tracks systemic inflammation. Over 120 days, the extract improved periodontal outcomes alongside standard treatment (PMID 42061085).
🧠 Brain — promising but mostly preclinical. A 2026 systematic review found olive polyphenols reduce neuroinflammation — a driver of Alzheimer's, Parkinson's, and age-related cognitive decline — across 32 in vivo studies (PMID 41082645). Oleuropein protected dopamine neurons in a Parkinson's model (PMID 42450163) and mitochondrial function in nerve cells (PMID 42299956). But human trials for brain aging remain essentially absent, and the field's own reviews flag that as the main gap (PMID 42072302).
🔬 Lifespan and senescence — the frontier. Extra-virgin olive oil rich in oleuropein extended lifespan and improved healthspan in C. elegans worms (PMID 41572070), and oleuropein reduced cellular senescence while improving wound healing in human cells (PMID 41727190). A 2026 review maps olive compounds' role in the inflammation-senescence loop behind osteoarthritis (PMID 42261702). These are encouraging mechanistic signals — but they sit at the preclinical end of the evidence.
Key Studies
| Study | Design | Key Finding |
|---|---|---|
| Lamti 2025 (PMID 40990594) | RCT, double-blind, multicenter (n=621, 12 wks) | 24-h systolic BP −6.4 mmHg vs −1.5 placebo (P<0.01); systolic BP load fell 53.9%→42.2%. |
| Lasfar 2025 (PMID 41340653) | RCT, double-blind (n=65 postmenopausal women, 12 wks) | 250 mg/day shifted tissue-aging markers (elastin, collagen, MMP-2, AGEs) favorably. |
| Fladerer-Grollitsch 2026 (PMID 41935461) | RCT, double-blind (n=70, 12 wks) | OLE 1,000 mg + potassium cut morning home systolic BP by 5.4 mmHg. |
| Forbes-Hernández 2026 (PMID 42061085) | RCT (OLIVAGING, n=60, ≥50 yrs, 120 days) | 40% oleuropein extract improved periodontal outcomes in older adults. |
| Lachovicz 2025 (PMID 40325976) | Systematic review & meta-analysis | Confirms olive leaf lowers BP in pre-hypertensive and hypertensive adults. |
| Álvares 2024 (PMID 38287654) | Meta-analysis (12 RCTs) | Olive leaf extract improves cardiometabolic risk factors. |
| Razmpoosh 2022 (PMID 36271405) | Meta-analysis (12 trials, n=819) | Significantly lowered triglycerides (−9.5 mg/dL) and systolic BP. |
| Polacchini 2025 (PMID 41257461) | Preclinical (human muscle cells) | Oleuropein aglycone activated AMPK/FOXO3a, autophagy, and mitochondria; cut oxidative stress ~43%. |
| Rodríguez-Candela Mateos 2026 (PMID 41727190) | Preclinical (human fibroblasts) | Oleuropein reduced cellular senescence and improved wound healing (senotherapeutic). |
| Zhang 2026 (PMID 41572070) | Preclinical (C. elegans) | Oleuropein-rich extra-virgin olive oil extended worm lifespan and healthspan. |
Dosing and Safety
Human trials have used roughly 250 to 1,000 mg per day of olive leaf extract, typically standardized to its oleuropein content. The 621-person blood-pressure trial and the OLE-plus-potassium trial used the higher end; the tissue-aging trial used just 250 mg. Commercial products usually standardize to 15–25% oleuropein, so a 500 mg capsule delivers roughly 75–125 mg of oleuropein:
| Goal | Typical Dose | Notes |
|---|---|---|
| General wellness / cardiometabolic support | 500 mg/day (15–25% oleuropein) | The most common commercial dose; start low to gauge tolerance. |
| Blood-pressure support (trial range) | 500–1,000 mg/day | The 621-person trial and OLE+potassium trial used this range (≥160 mg oleuropein). |
| Tissue-aging / lower-dose maintenance | 250 mg/day | The dose used in the postmenopausal tissue-aging trial (PMID 41340653). |
Form and sourcing: Choose a standardized extract that lists its oleuropein content (ideally 15–25%). The compound is bitter, so capsules are more palatable than teas or tinctures. Avoid unstandardized "whole leaf" powders when possible — active content varies widely between batches.
Safety notes:
- Generally well tolerated. Trials report few side effects, and olive leaf has a long food-use history. The most common complaints are mild digestive upset.
- Blood-pressure lowering — the main caution. Olive leaf genuinely lowers blood pressure, so it can add to the effect of antihypertensive drugs and cause dizziness or low pressure in some people. If you take BP medication, monitor your readings and involve your doctor (PMID 40990594, 40325976).
- Blood-sugar lowering. It can also modestly lower blood sugar, so people on diabetes medication should monitor and be aware of a possible additive effect (PMID 36271405).
- Allergy: Anyone with an olive or pollen allergy should avoid it.
- Pregnancy and breastfeeding: Avoid concentrated extracts — there is no reliable safety data for these populations.
❓ Common Questions About Olive Leaf Extract
What is olive leaf extract and how does it work?
Olive leaf extract is a concentrated extract of olive tree leaves. Its main active compound, oleuropein, activates AMPK — a cellular energy sensor that mimics some effects of calorie restriction — while also reducing inflammation and supporting the energy factories inside your cells called mitochondria.
What does the evidence actually show?
The evidence is 🥈 Silver overall, but Gold-level for blood pressure and heart-health markers. A 621-person trial lowered 24-hour blood pressure by 6.4 points, meta-analyses confirm lower triglycerides and blood pressure, and one 65-woman trial found it shifted real tissue-aging markers. What's missing is proof that it extends human lifespan itself.
What's the right dose?
Trials used 250 to 1,000 mg per day. A common starting dose is 500 mg a day of an extract standardized to 15–25% oleuropein, taken with food. For blood pressure, the higher 500–1,000 mg range matches the trials, but start low and monitor your readings.
What are the risks and side effects?
Olive leaf extract is generally well tolerated, with mild digestive upset being the most common side effect. The main risk is its real blood-pressure-lowering effect, which can cause dizziness or low blood pressure when combined with blood-pressure or diabetes medication.
Who should avoid it?
Anyone on blood-pressure or diabetes medication should only use it under a doctor's supervision, since the effects can stack. Pregnant or breastfeeding women, and people with olive or pollen allergies, should avoid concentrated extracts.
The Bottom Line
Olive leaf extract is one of the better-evidenced natural supplements for cardiovascular aging — and it has a real, if early, anti-aging signal behind it. The blood-pressure evidence is the standout: a 621-person double-blind trial, a second combination trial, and three separate meta-analyses all point the same way, and a 6.4 mmHg drop in 24-hour systolic pressure is clinically meaningful (PMID 40990594, 41935461, 40325976, 38287654, 36271405). Add the tissue-aging trial in postmenopausal women — one of the few supplement studies to measure aging biomarkers directly — and you have a coherent story (PMID 41340653).
What's missing is the last mile. No human trial has shown olive leaf extract extends lifespan or slows biological aging itself. The most exciting longevity mechanisms — AMPK activation, senescence reduction, mitochondrial biogenesis, lifespan extension in worms — are solid but preclinical (PMID 41257461, 41727190, 42299956, 41572070). And oleuropein's poor bioavailability means the dose that reaches your tissues may be lower than the label implies. Anyone selling olive leaf as a proven anti-aging molecule is ahead of the evidence.
Our verdict: 🥈 Silver overall, with 🥇 Gold-level evidence for blood pressure and cardiometabolic support. Who it's for: adults — especially 40+ — looking to support healthy blood pressure, cholesterol, and the cardiovascular side of aging with a low-risk, well-studied supplement, and who like the Mediterranean-diet connection. Who it's not for: anyone on blood-pressure or diabetes medication (without medical supervision), pregnant or breastfeeding women, or anyone expecting a proven lifespan extension. If you take it: a standardized extract (15–25% oleuropein) at 250–1,000 mg a day with food, and keep the blood-pressure stacking effect in mind.
Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Olive leaf extract is a dietary supplement and is not approved to treat, cure, or prevent any disease. Always consult a qualified healthcare provider before starting any supplement, especially if you take blood-pressure or diabetes medication, have low blood pressure, are allergic to olives or pollen, or are pregnant or breastfeeding. Read our full disclaimer →
Sources
- Lamti F, Trabelsi I, Dhaoui R, et al. Efficacy of olive leaf extracts in controlling blood pressure in hypertensive patients: a double-blind randomized clinical trial. J Hypertens. 2025. PMID 40990594
- Lasfar A, van Stratum SLM, Imperatrice M, et al. Effects of olive leaf extract supplementation on systemic markers of tissue aging and remodeling in postmenopausal women. Front Nutr. 2025. PMID 41340653
- Fladerer-Grollitsch JP, Bucar F, Klein T, et al. Effects of a combination of olive leaf extract and potassium on blood pressure in participants with mild to moderate hypertension. Phytomedicine. 2026. PMID 41935461
- Forbes-Hernández TY, Vargas-Corral FG, Bullón B, et al. Adjuvant treatment with an oleuropein-enriched olive leaf extract improves periodontal outcomes in older adults with periodontitis. Phytomedicine. 2026. PMID 42061085
- Lachovicz R, Ferro-Lebres V, Almeida-de-Souza J, et al. Efficacy of olive leaf extract in improving blood pressure in pre-hypertensive and hypertensive individuals: a systematic review and meta-analysis. Phytother Res. 2025. PMID 40325976
- Álvares AA, Garcêz A, Silva LT, et al. Olive leaf extract effect on cardiometabolic risk factors: a systematic review and meta-analysis of randomized clinical trials. Nutr Rev. 2024. PMID 38287654
- Razmpoosh E, Abdollahi S, Mousavirad M, et al. The effects of olive leaf extract on cardiovascular risk factors in the general adult population: a systematic review and meta-analysis of randomized controlled trials. Diabetol Metab Syndr. 2022. PMID 36271405
- Polacchini G, Venerando A, Bigot A, et al. Oleuropein aglycone modulates oxidative stress and autophagy-related pathways in human skeletal muscle cells. Biofactors. 2025. PMID 41257461
- Rodríguez-Candela Mateos M, García-Fernández J, Saraiva SM, et al. Nanoencapsulated senotherapeutic compounds targeting connexin-43 for enhanced wound healing. iScience. 2026. PMID 41727190
- Zhang T, Zhao J, Dong W, et al. Characterization and mechanistic insights into the antioxidant and anti-aging components of extra virgin olive oil. Plant Foods Hum Nutr. 2026. PMID 41572070
- Leri M, Nosi D, Ami D, et al. Oleuropein and hydroxytyrosol enhance mitochondrial function and biogenesis in SH-SY5Y cells through estrogen-like mechanisms. Food Funct. 2026. PMID 42299956
- Medoro A, Scapagnini G, Hu FB, et al. Neuroprotective effects of olive oil and its phenolic compounds on neuroinflammation: a systematic review. Nutr Neurosci. 2026. PMID 41082645
- Medoro A, Tardugno R, Davinelli S, et al. Crosstalk between inflammation and cellular senescence in osteoarthritis: modulatory actions of olive oil and its bioactive compounds. Mediators Inflamm. 2026. PMID 42261702
- Debnath M, Sharma S, Joshi S, et al. Epigenetic regulations by olive bioactives: targeting HDAC for disease prevention and therapy. Curr Nutr Rep. 2026. PMID 42371247
- Dabravolski SA, Pleshko EM, Sukhorukov VN, et al. Use of olives-derived phytochemicals for prevention and treatment of atherosclerosis: an update. Curr Top Med Chem. 2024. PMID 39162269